Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial

BACKGROUND: To study the effectiveness of an aromatase inhibitor (Anastrozole) associated with levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. METHODS: Prospective, randomized clinical trial. Setting: University Hospital (single center). Elegibility...

Descripción completa

Detalles Bibliográficos
Autores principales: Acién, Pedro, Velasco, Irene, Acién, Maribel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138989/
https://www.ncbi.nlm.nih.gov/pubmed/34016111
http://dx.doi.org/10.1186/s12905-021-01347-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138989/
https://www.ncbi.nlm.nih.gov/pubmed/34016111
http://dx.doi.org/10.1186/s12905-021-01347-9

Ejemplares similares